Pregnancy in Women with SLE

Dubois' Lupus Erythematosus and Related Syndromes: Eighth Edition

Volumn , Issue , 2013, Pages 455-463

  Clowse, Megan E B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84938797047     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-1893-5.00036-4     Document Type: Chapter

References (75)

1. Clark CA, Spitzer KA, Laskin CA Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 2005, 32(9):1709-1712.
2. Mitchell K, Kaul M, Clowse ME The management of rheumatic diseases in pregnancy. Scand J Rheumatol 2010, 39(2):99-108.
3. Chakravarty EF, Nelson L, Krishnan E Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006, 54(3):899-907.
4. Clowse ME, Jamison M, Myers E, et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008, 199(2):127. e1-e6.
5. Clowse ME Lupus activity in pregnancy. Rheum Dis Clin North Am 2007, 33(2):237-252. v.
6. Maynard SE, Karumanchi SA, Thadhani RI Hypertension and kidney disease in pregnancy. Brenner and Rector's the kidney 2007, Saunders Elsevier, Philadelphia. ed 8. B. Brenner (Ed.).
7. James AH, Brancazio LR, Ortel TL Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy. Clin Adv Hematol Oncol 2005, 3(3):187-197.
8. Hunt JS, Langat DL HLA-G: a human pregnancy-related immunomodulator. Curr Opin Pharmacol 2009, 9(4):462-469.
9. Munoz-Suano A, Hamilton AB, Betz AG Gimme shelter: the immune system during pregnancy. Immunol Rev 2011, 241(1):20-38.
10. Carmona F, Font J, Cervera R, et al. Obstetrical outcome of pregnancy in patients with systemic lupus erythematosus. A study of 60 cases. Eur J Obstet Gynecol Reprod Biol 1999, 83(2):37-142.
11. Chakravarty EF, Colón I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 2005, 192(6):1897-1904.
12. Clowse ME, Magder LS, Witter F, et al. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005, 52(2):514-521.
13. Cortés-Hernández J, Ordi-Ros J, Paredes F, et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford) 2002, 41(6):643-650.
14. Lima F, Buchanan NM, Khamashta MA, et al. Obstetric outcome in systemic lupus erythematosus. Semin Arthritis Rheum 1995, 25(3):184-192.
15. Rubbert A, Pimer K, Wildt L, et al. Pregnancy course and complications in patients with systemic lupus erythematosus. Am J Reprod Immunol 1992, 28(3-4):205-207.
16. Tincani A, Faden D, Tarantini M, et al. Systemic lupus erythematosus and pregnancy: a prospective study. Clin Exp Rheumatol 1992, 10(5):439-446.
17. Urowitz MB, Gladman DD, Farewell VT, et al. Lupus and pregnancy studies. Arthritis Rheum 1993, 36(10):1392-1397.
18. Clowse ME, Madger LS, Witter F, et al. Early risk factors for pregnancy loss in lupus. Obstet Gynecol 2006, 107(2 Pt 1):293-299.
19. Clowse ME, Madger LS, Witter F, et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 2006, 54(11):3640-3647.
20. Østensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006, 8(3):209.
21. Clark CA, Spitzer KA, Nadler JN, et al. Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol 2003, 30(10):2127-2132.
22. Clowse ME, Jamison M, Myers E, et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 2008, 199(2):127. e1-e6.
23. Smyth A, Oliveira GH, Lahr BD, et al. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol 2010, 5(11):2060-2068.
24. Georgiou PE, Politi EN, Katsimbri P, et al. Outcome of lupus pregnancy: a controlled study. Rheumatology (Oxford) 2000, 39(9):1014-1019.
25. Cavallasca JA, Laborde HA, Ruda-Vega H, et al. Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE). Clin Rheumatol 2008, 27(1):41-46.
26. Kwok LW, Tam LS, Zhu T, et al. Predictors of maternal and fetal outcomes in pregnancies of patients with systemic lupus erythematosus. Lupus 2011, 20(8):829-836.
27. Yasmeen S, Wilkins EE, Field NT, et al. Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med 2001, 10(2):91-96.
28. Wong KL, Chan FY, Lee CP Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med 1991, 151(2):269-273.
29. Johnson MJ, Petri M, Witter FR, et al. Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol 1995, 86(3):396-399.
30. Magid MS, Kaplan C, Sammaritano LR, et al. Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 1998, 179(1):226-234.
31. Moroni G, Ponticelli C The risk of pregnancy in patients with lupus nephritis. J Nephrol 2003, 16(2):161-167.
32. Qazi UM, Petri M Autoantibodies, low complement, and obesity predict preeclampsia in SLE: a case-control study. Arthritis Rheum 2006, 54(9 Suppl):S264.
33. Carmona F, Font J, Moga I, et al. Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am J Reprod Immunol 2005, 53(4):182-188.
34. Lamarca B The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia. Minerva Ginecol 2010, 62(2):105-120.
35. Qazi U, Lam C, Karumanchi SA, et al. Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus. J Rheumatol 2008, 35(4):631-634.
36. Duley L, Henderson-Smart DJ, Meher S, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007, 2:CD004659.
37. Cervera R, Khamashta MA Epidemiology of systemic lupus erythematosus at the change of the millennium: lessons from the Euro-Lupus and the LUMINA projects. Lupus 2006, 15(1):1-2.
38. Petri M, Howard D, Repke J, et al. The Hopkins Lupus Pregnancy Center: 1987-1991 update. Am J Reprod Immunol 1992, 28(3-4):188-191.
39. Rahman FZ, Rahman J, Al-Suleiman SA, et al. Pregnancy outcome in lupus nephropathy. Arch Gynecol Obstet 2005, 271(3):222-226.
40. Wagner SJ, Craici I, Reed D, et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus 2009, 18(4):342-347.
41. Jungers P, Dougados M, Pélissier C, et al. Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Med 1982, 142(4):771-776.
42. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4(2):295-306.
43. Bick RL Antiphospholipid syndrome in pregnancy. Hematol Oncol Clin North Am 2008, 22(1):107-120. vii.
44. Salmon JE, Girardi G Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation. J Reprod Immunol 2008, 77(1):51-56.
45. Rai RS, Clifford K, Cohen H, et al. High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995, 10(12):3301-3304.
46. Empson M, Lassere M, Craig JC, et al. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials. Obstet Gynecol 2002, 99(1):135-144.
47. Kutteh WH Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996, 174(5):1584-1589.
48. Farquharson RG, Quenby S, Greaves M Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002, 100(3):408-413.
49. Rai R, Cohen H, Dave M, et al. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997, 314(7076):253-257.
50. Clark EA, Silver RM, Branch DW Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?. Curr Rheumatol Rep 2007, 9(3):219-225.
51. Branch DW, Silver RM, Porter TF Obstetric antiphospholipid syndrome: current uncertainties should guide our way. Lupus 2010, 19(4):446-452.
52. Derksen RH, Khamashta MA, Branch DW Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 2004, 50(4):1028-1039.
53. Bates SM, Greer IA, Hirsh J, et al. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126(3 Suppl):627S-644S.
54. Li DK, Liu L, Odouli R Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ 2003, 327(7411):368.
55. Scherle PA, Ma W, Lim H, et al. Regulation of cyclooxygenase-2 induction in the mouse uterus during decidualization. An event of early pregnancy. J Biol Chem 2000, 275(47):37086-37092.
56. Topuz S, Has R, Ermiş H, et al. Acute severe reversible oligohydramnios induced by indomethacin in a patient with rheumatoid arthritis: a case report and review of the literature. Clin Exp Obstet Gynecol 2004, 31(1):70-72.
57. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000, 62(6):385-392.
58. Costedoat-Chalumeau N, Amoura Z, Le Thi Hong D, et al. Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block. Ann Rheum Dis 2003, 62(10):1010-1012.
59. A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. N Engl J Med 1991, 324(3):150-154. No author.
60. Costedoat-Chalumeau N, Amoura Z, Duhaut P, et al. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 2003, 48(11):3207-3211.
61. Klinger G, Morad Y, Westall CA, et al. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet 2001, 358(9284):813-814.
62. Motta M, Tincani A, Faden D, et al. Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol 2005, 25(2):86-89.
63. Polifka JE, Friedman JM Teratogen update: azathioprine and 6-mercaptopurine. Teratology 2002, 65(5):240-261.
64. Miniero R, Tardivo I, Curtoni ES, et al. Pregnancy after renal transplantation in Italian patients: focus on fetal outcome. J Nephrol 2002, 15(6):626-632.
65. Clowse MEB, Magder LS, Witter F, et al. Azathioprine use in lupus pregnancy. Arthritis Rheum 2005, 52(9 Suppl):S386-S387.
66. Armenti VT, Daller JA, Constantiescu S, et al. Report from the National Transplantation Pregnancy Registry: outcomes of pregnancy after transplantation. Clin Transpl 2006, 57-70.
67. Hussein MM, Mooij JM, Roujouleh H Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy. Clin Nephrol 1993, 40(3):160-163.
68. Doria A, Di Lenardo L, Vario S, et al. Cyclosporin A in a pregnant patient affected with systemic lupus erythematosus. Rheumatol Int 1992, 12(2):77-78.
69. Gwyn KM, Theriault RL Breast cancer during pregnancy. Curr Treat Options Oncol 2000, 1(3):239-243.
70. Clowse ME, Magder L, Petri M Cyclophosphamide for lupus during pregnancy. Lupus 2005, 14(8):593-597.
71. Kart Köseoglu H, Yücel AE, Künefeci G, et al. Cyclophosphamide therapy in a serious case of lupus nephritis during pregnancy. Lupus 2001, 10(11):818-820.
72. Rauova L, Lukac J, Levy Y, et al. High-dose intravenous immunoglobulins for lupus nephritis-a salvage immunomodulation. Lupus 2001, 10(3):209-213.
73. Perricone R, De Carolis C, Kröegler B, et al. Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion. Rheumatology (Oxford) 2008, 47(5):646-651.
74. Chakravarty EF, Murray ER, Kelman A, et al. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011, 117(5):1499-1506.
75. Auyeung-Kim DJ, Devalaraja MN, Migone TS, et al. Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator. Reprod Toxicol 2009, 28(4):443-455.